STAAB THOMAS R II
Insider CIK 1230708 · LNSR Chief Financial Officer · TENX Chief Financial Officer · BCRX Senior Vice President and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-11 | 2026-09-15 | 5,675 | $1.94 | $11.0K | 15,675 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-11 | 2026-09-15 | 5,675 | $1.94 | $11.0K | 15,675 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2026-05-11 | 2026-05-13 | 450,000 | — | $0 | 450,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award | 2026-05-11 | 2026-05-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LNSR LENSAR, Inc. | F Tax w/h | 2026-05-06 | 2026-05-08 | 1,350 | $5.39 | $7.3K | 174,609 | SEC↗ |
| LNSR LENSAR, Inc. | M Exercise deriv | 2026-03-19 | 2026-03-19 | 5,500 | — | $0 | 14,295 | SEC↗ |
| LNSR LENSAR, Inc. | M Exercise | 2026-03-19 | 2026-03-19 | 5,500 | $2.65 | $14.6K | 175,959 | SEC↗ |
| LNSR LENSAR, Inc. | F Tax w/h | 2026-02-18 | 2026-02-20 | 1,076 | $11.32 | $12.2K | 170,459 | SEC↗ |
| LNSR LENSAR, Inc. | F Tax w/h | 2026-01-11 | 2026-01-13 | 1,826 | $11.57 | $21.1K | 171,535 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2025-02-18 | 2025-02-20 | 12,766 | — | $0 | 173,361 | SEC↗ |
| LNSR LENSAR, Inc. | F Tax w/h | 2025-01-11 | 2025-02-06 | 1,839 | $8.25 | $15.2K | 160,595 | SEC↗ |
| LNSR LENSAR, Inc. | M Exercise deriv | 2024-08-08 | 2024-08-12 | 3,500 | — | $0 | 19,795 | SEC↗ |
| LNSR LENSAR, Inc. | M Exercise | 2024-08-08 | 2024-08-12 | 3,500 | $2.65 | $9.3K | 162,434 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2024-05-06 | 2024-05-08 | 19,000 | — | $0 | 158,934 | SEC↗ |
| LNSR LENSAR, Inc. | F Tax w/h | 2024-01-11 | 2024-05-08 | 1,853 | $4.43 | $8.2K | 139,934 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2023-01-11 | 2023-01-13 | 23,295 | — | $0 | 23,295 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2023-01-11 | 2023-01-13 | 6,656 | — | $0 | 141,787 | SEC↗ |
| LNSR LENSAR, Inc. | P Buy | 2022-12-07 | 2022-12-07 | 727 | $3.16 | $2.3K | 135,131 | SEC↗ |
| LNSR LENSAR, Inc. | P Buy | 2022-12-06 | 2022-12-07 | 2,025 | $3.16 | $6.4K | 134,404 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2022-01-11 | 2022-01-13 | 52,500 | — | $0 | 52,500 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2022-01-11 | 2022-01-13 | 15,000 | — | $0 | 131,409 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2021-04-12 | 2021-04-14 | 49,197 | — | $0 | 49,197 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2020-12-07 | 2020-12-10 | 19,276 | — | $0 | 115,657 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-21 | 2020-02-25 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-14 | 2020-02-19 | 31,500 | — | $0 | 31,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-19 | 165,000 | — | $0 | 165,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-26 | 127,000 | — | $0 | 127,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-17 | 2019-05-20 | 2,500 | $7.45 | $18.6K | 125,176 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-05-16 | 2019-05-20 | 4,750 | — | $0 | 61,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-16 | 2019-05-20 | 7,250 | $7.72 | $56.0K | 127,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-05-16 | 2019-05-20 | 4,750 | $1.42 | $6.7K | 134,926 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-05-15 | 2019-05-16 | 4,750 | — | $0 | 65,750 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-15 | 2019-05-16 | 7,250 | $7.92 | $57.4K | 130,176 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-05-15 | 2019-05-16 | 4,750 | $1.42 | $6.7K | 137,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-05-14 | 2019-05-16 | 4,500 | — | $0 | 70,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-05-14 | 2019-05-16 | 4,500 | $1.42 | $6.4K | 137,176 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-14 | 2019-05-16 | 4,500 | $7.62 | $34.3K | 132,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-05-13 | 2019-05-13 | 9,750 | — | $0 | 131,250 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-13 | 2019-05-13 | 9,750 | $7.76 | $75.7K | 132,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-05-13 | 2019-05-13 | 9,750 | $5.51 | $53.7K | 142,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-05-09 | 2019-05-13 | 9,750 | — | $0 | 141,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-09 | 2019-05-13 | 9,750 | $7.63 | $74.4K | 132,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-05-09 | 2019-05-13 | 9,750 | $5.51 | $53.7K | 142,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-05-06 | 2019-05-06 | 9,000 | — | $0 | 150,750 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-05-06 | 2019-05-06 | 9,000 | $5.51 | $49.6K | 141,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-06 | 2019-05-06 | 9,000 | $7.75 | $69.8K | 132,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-05-02 | 2019-05-06 | 7,750 | — | $0 | 159,750 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-05-02 | 2019-05-06 | 7,750 | $5.51 | $42.7K | 140,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-05-02 | 2019-05-06 | 7,750 | $7.30 | $56.6K | 132,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-04-04 | 2019-04-08 | 7,500 | — | $0 | 167,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-04-04 | 2019-04-08 | 7,500 | $5.51 | $41.3K | 140,176 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-04-04 | 2019-04-08 | 7,500 | $8.81 | $66.1K | 132,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-28 | 2019-01-30 | 5,000 | — | $0 | 7,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-01-28 | 2019-01-30 | 5,000 | $9.85 | $49.3K | 128,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-28 | 2019-01-30 | 5,000 | $5.45 | $27.3K | 133,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2019-01-01 | 2019-01-03 | 785 | $8.07 | $6.3K | 132,676 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-12-20 | 2018-12-21 | 235,000 | — | $0 | 235,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-12-04 | 2018-12-06 | 3,922 | $9.45 | $37.1K | 133,461 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-23 | 2018-11-26 | 3,500 | — | $0 | 28,305 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-23 | 2018-11-26 | 3,500 | $9.66 | $33.8K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-23 | 2018-11-26 | 3,500 | $3.78 | $13.2K | 140,883 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-21 | 2018-11-26 | 5,000 | — | $0 | 12,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-21 | 2018-11-26 | 7,000 | — | $0 | 31,805 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-21 | 2018-11-26 | 7,000 | $9.08 | $63.6K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-21 | 2018-11-26 | 5,000 | $5.45 | $27.3K | 142,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-21 | 2018-11-26 | 5,000 | $9.41 | $47.0K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-21 | 2018-11-26 | 7,000 | $3.78 | $26.5K | 144,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-20 | 2018-11-21 | 6,500 | — | $0 | 97,071 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-20 | 2018-11-21 | 4,623 | — | $0 | 38,805 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-20 | 2018-11-21 | 6,500 | $3.22 | $20.9K | 143,883 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-20 | 2018-11-21 | 4,623 | $3.78 | $17.5K | 142,006 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-20 | 2018-11-21 | 4,623 | $8.57 | $39.6K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-20 | 2018-11-21 | 6,500 | $8.75 | $56.9K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-19 | 2018-11-21 | 75 | — | $0 | 43,428 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-19 | 2018-11-21 | 75 | $3.78 | $284 | 137,458 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-19 | 2018-11-21 | 75 | $8.30 | $623 | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-08 | 2018-11-09 | 2,302 | — | $0 | 43,503 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-08 | 2018-11-09 | 11,113 | — | $0 | 103,571 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-08 | 2018-11-09 | 2,302 | $3.78 | $8.7K | 139,685 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-08 | 2018-11-09 | 2,302 | $8.30 | $19.1K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-08 | 2018-11-09 | 11,113 | $8.09 | $89.9K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-08 | 2018-11-09 | 11,113 | $3.22 | $35.8K | 148,496 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-07 | 2018-11-09 | 672 | — | $0 | 114,684 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-07 | 2018-11-09 | 672 | $8.00 | $5.4K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-07 | 2018-11-09 | 672 | $3.22 | $2.2K | 138,055 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-05 | 2018-11-07 | 215 | — | $0 | 115,356 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-05 | 2018-11-07 | 215 | $3.22 | $692 | 137,598 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-05 | 2018-11-07 | 215 | $8.00 | $1.7K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-02 | 2018-11-06 | 3,500 | — | $0 | 45,805 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-02 | 2018-11-06 | 7,356 | — | $0 | 115,571 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-02 | 2018-11-06 | 7,356 | $3.22 | $23.7K | 144,739 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-02 | 2018-11-06 | 7,356 | $7.78 | $57.2K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-02 | 2018-11-06 | 3,500 | $7.96 | $27.9K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-02 | 2018-11-06 | 3,500 | $3.78 | $13.2K | 140,883 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-10-19 | 2018-10-23 | 3,150 | — | $0 | 49,305 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-10-19 | 2018-10-23 | 3,150 | $3.78 | $11.9K | 140,533 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-10-19 | 2018-10-23 | 3,150 | $7.45 | $23.5K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-10-03 | 2018-10-04 | 972 | — | $0 | 122,927 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-10-03 | 2018-10-04 | 100 | — | $0 | 52,455 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-10-03 | 2018-10-04 | 100 | $3.78 | $378 | 137,483 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-10-03 | 2018-10-04 | 972 | $3.22 | $3.1K | 138,355 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-10-03 | 2018-10-04 | 972 | $7.26 | $7.1K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-10-03 | 2018-10-04 | 100 | $7.45 | $745 | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-10-02 | 2018-10-04 | 5,528 | — | $0 | 123,899 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-10-02 | 2018-10-04 | 3,250 | — | $0 | 52,555 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-10-02 | 2018-10-04 | 3,250 | $3.78 | $12.3K | 140,633 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-10-02 | 2018-10-04 | 3,250 | $7.19 | $23.4K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-10-02 | 2018-10-04 | 5,528 | $3.22 | $17.8K | 142,911 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-10-02 | 2018-10-04 | 5,528 | $7.27 | $40.2K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-20 | 2018-01-23 | 3,979 | $5.59 | $22.2K | 137,383 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-01 | 2018-01-03 | 852 | $4.91 | $4.2K | 141,362 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-12-20 | 2017-12-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-08-31 | 2017-09-05 | 27,000 | — | $0 | 27,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-05-22 | 2017-05-24 | 7,750 | — | $0 | 4,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-05-22 | 2017-05-24 | 7,750 | $4.73 | $36.7K | 149,210 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-05-22 | 2017-05-24 | 6,996 | $5.24 | $36.7K | 142,214 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-03-20 | 2017-03-22 | 3,250 | — | $0 | 55,805 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2017-03-20 | 2017-03-22 | 3,250 | $9.20 | $29.9K | 141,460 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-03-20 | 2017-03-22 | 3,250 | $3.78 | $12.3K | 144,710 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-03-16 | 2017-03-20 | 23,955 | — | $0 | 59,055 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-03-16 | 2017-03-20 | 12,500 | — | $0 | 75,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-03-16 | 2017-03-20 | 12,308 | $8.80 | $108.3K | 141,460 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-03-16 | 2017-03-20 | 12,500 | $1.42 | $17.8K | 153,768 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-03-16 | 2017-03-20 | 23,955 | $3.78 | $90.5K | 141,268 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-03-10 | 2017-03-14 | 3,250 | — | $0 | 83,010 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2017-03-10 | 2017-03-14 | 3,250 | $9.06 | $29.4K | 117,313 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-03-10 | 2017-03-14 | 3,250 | $3.78 | $12.3K | 120,563 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-03-08 | 2017-03-10 | 6,500 | — | $0 | 86,260 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2017-03-08 | 2017-03-10 | 3,250 | $8.65 | $28.1K | 117,313 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-03-08 | 2017-03-10 | 6,500 | $3.78 | $24.6K | 123,813 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2017-03-08 | 2017-03-10 | 3,250 | $8.20 | $26.6K | 120,563 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-03-06 | 2017-03-08 | 3,250 | — | $0 | 92,760 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2017-03-06 | 2017-03-08 | 3,250 | $7.90 | $25.7K | 117,313 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-03-06 | 2017-03-08 | 3,250 | $3.78 | $12.3K | 120,563 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-02-27 | 2017-03-01 | 175,000 | — | $0 | 175,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-20 | 2017-01-24 | 5,198 | $5.95 | $30.9K | 117,313 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-01 | 2017-01-03 | 1,676 | $6.33 | $10.6K | 122,511 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2016-12-19 | 2016-12-21 | 3,250 | — | $0 | 96,010 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2016-12-19 | 2016-12-21 | 3,250 | $3.78 | $12.3K | 127,437 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2016-12-19 | 2016-12-21 | 3,250 | $7.45 | $24.2K | 124,187 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2016-08-12 | 2016-08-15 | 4,558 | $5.22 | $23.8K | 124,187 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2016-08-11 | 2016-08-15 | 1,306 | $5.05 | $6.6K | 128,745 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2016-08-09 | 2016-08-11 | 14,577 | $4.43 | $64.6K | 130,051 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 129,427 | — | $0 | 129,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-03-01 | 2016-03-03 | 465 | $2.13 | $990 | 144,628 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-20 | 2016-01-22 | 4,823 | $7.55 | $36.4K | 145,093 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2016-01-19 | 2016-01-21 | 2,500 | — | $0 | 99,260 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2016-01-19 | 2016-01-21 | 12,500 | — | $0 | 87,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2016-01-19 | 2016-01-21 | 2,500 | $3.78 | $9.4K | 137,416 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2016-01-19 | 2016-01-21 | 12,500 | $1.42 | $17.8K | 149,916 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-01 | 2016-01-05 | 1,676 | $10.32 | $17.3K | 134,916 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-12-29 | 2015-12-31 | 62,573 | — | $0 | 62,573 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-12-21 | 2015-12-22 | 3,052 | $10.86 | $33.1K | 136,592 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-12-17 | 2015-12-18 | 3,000 | $10.49 | $31.5K | 139,644 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-07-20 | 2015-07-22 | 3,500 | $16.50 | $57.8K | 142,644 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-06-22 | 2015-06-24 | 3,750 | — | $0 | 11,750 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-22 | 2015-06-24 | 3,750 | $16.00 | $60.0K | 146,144 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-06-22 | 2015-06-24 | 3,750 | $4.73 | $17.7K | 149,894 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-06-19 | 2015-06-22 | 3,175 | — | $0 | 101,760 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-06-19 | 2015-06-22 | 3,175 | $3.78 | $12.0K | 149,319 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-19 | 2015-06-22 | 3,500 | $15.00 | $52.5K | 146,144 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-19 | 2015-06-22 | 3,175 | $15.00 | $47.6K | 146,144 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-06-18 | 2015-06-22 | 3,100 | — | $0 | 108,035 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-06-18 | 2015-06-22 | 3,100 | — | $0 | 104,935 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-06-18 | 2015-06-22 | 3,100 | $3.78 | $11.7K | 155,844 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-18 | 2015-06-22 | 3,500 | $14.00 | $49.0K | 149,644 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-06-18 | 2015-06-22 | 3,100 | $3.78 | $11.7K | 152,744 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-18 | 2015-06-22 | 3,100 | $14.25 | $44.2K | 152,744 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-18 | 2015-06-22 | 3,100 | $13.50 | $41.9K | 149,644 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-05 | 2015-06-09 | 6,000 | $12.75 | $76.5K | 153,144 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-01 | 2015-06-02 | 3,000 | $12.00 | $36.0K | 159,144 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-05-18 | 2015-05-19 | 3,000 | $11.00 | $33.0K | 162,144 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-13 | 2015-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-03-01 | 2015-03-03 | 465 | $10.20 | $4.7K | 165,144 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-20 | 2015-01-22 | 4,476 | $11.17 | $50.0K | 164,913 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-01-01 | 2015-01-05 | 42,400 | — | $0 | 42,400 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-01-01 | 2015-01-05 | 8,900 | — | $0 | 171,842 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-01 | 2015-01-05 | 2,453 | $12.16 | $29.8K | 169,389 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-12-29 | 2014-12-31 | 9,500 | — | $0 | 111,135 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-12-29 | 2014-12-31 | 9,500 | $3.78 | $35.9K | 172,442 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-12-29 | 2014-12-31 | 9,500 | $12.56 | $119.3K | 162,942 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-12-19 | 2014-12-23 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-08-27 | 2014-08-29 | 10,000 | — | $0 | 7,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-08-27 | 2014-08-29 | 10,000 | $13.58 | $135.8K | 162,942 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-08-27 | 2014-08-29 | 10,000 | $5.45 | $54.5K | 172,942 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-07-25 | 2014-07-28 | 26,455 | — | $0 | 120,635 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-07-25 | 2014-07-28 | 26,455 | $3.78 | $100.0K | 170,756 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-07-25 | 2014-07-28 | 8,504 | $11.76 | $100.0K | 162,252 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-07-01 | 2014-07-02 | 3,125 | — | $0 | 15,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-07-01 | 2014-07-02 | 3,125 | $4.73 | $14.8K | 147,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-07-01 | 2014-07-02 | 3,125 | $13.00 | $40.6K | 144,301 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-06-23 | 2014-06-24 | 3,125 | — | $0 | 18,625 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-06-23 | 2014-06-24 | 3,125 | $12.49 | $39.0K | 144,301 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-06-23 | 2014-06-24 | 3,125 | $4.73 | $14.8K | 147,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-06-17 | 2014-06-19 | 3,125 | — | $0 | 21,750 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-06-17 | 2014-06-19 | 3,125 | $4.73 | $14.8K | 147,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-06-17 | 2014-06-19 | 3,125 | $12.00 | $37.5K | 144,301 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-26 | 2014-05-28 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-05-22 | 2014-05-27 | 17,685 | — | $0 | 147,090 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-05-22 | 2014-05-27 | 17,685 | $3.78 | $66.8K | 144,301 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-14 | 2014-03-17 | 3,125 | — | $0 | 24,875 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-03-14 | 2014-03-17 | 3,125 | $11.24 | $35.1K | 126,616 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-14 | 2014-03-17 | 3,125 | $4.73 | $14.8K | 129,741 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 3,000 | — | $0 | 28,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-03-04 | 2014-03-07 | 3,000 | $12.69 | $38.1K | 126,616 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 3,000 | $4.73 | $14.2K | 129,616 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-03-01 | 2014-03-07 | 461 | $11.69 | $5.4K | 126,616 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-01-20 | 2014-02-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2014-01-20 | 2014-02-04 | 54,000 | — | $0 | 126,218 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-01-13 | 2014-01-15 | 35,225 | — | $0 | 164,775 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-01-13 | 2014-01-15 | 12,621 | $10.55 | $133.2K | 72,218 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-01-13 | 2014-01-15 | 35,225 | $3.78 | $133.2K | 84,839 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-01-01 | 2014-01-03 | 2,453 | $7.60 | $18.6K | 49,614 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2013-03-01 | 2013-03-06 | 542 | $1.19 | $645 | 49,322 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-31 | 2013-03-14 | 2,745 | $1.38 | $3.8K | 52,609 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 8,500 | — | $0 | 49,864 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 8,500 | — | $0 | 41,364 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2012-07-01 | 2012-07-02 | 8,113 | $3.97 | $32.2K | 31,617 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2012-03-15 | 2012-03-19 | 4,162 | $5.23 | $21.8K | 37,124 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-15 | 2012-03-19 | 11,989 | — | $0 | 41,286 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-03-01 | 2012-03-05 | 31,000 | $4.73 | $146.6K | 31,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-01 | 2012-03-05 | 5,600 | — | $0 | 30,600 | SEC↗ |